Insulet Stock (NASDAQ:PODD)
Previous Close
$261.16
52W Range
$160.19 - $279.40
50D Avg
$236.86
200D Avg
$197.73
Market Cap
$18.25B
Avg Vol (3M)
$630.05K
Beta
1.22
Div Yield
-
PODD Company Profile
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
PODD Performance
Peer Comparison
| Ticker | Company |
|---|---|
| TMDX | TransMedics Group, Inc. |
| IART | Integra LifeSciences Holdings Corporation |
| MASI | Masimo Corporation |
| ABT | Abbott Laboratories |
| INMD | InMode Ltd. |
| SYK | Stryker Corporation |
| EW | Edwards Lifesciences Corporation |
| PEN | Penumbra, Inc. |
| DXCM | DexCom, Inc. |
| GKOS | Glaukos Corporation |
| NARI | Inari Medical, Inc. |
| TNDM | Tandem Diabetes Care, Inc. |
| ALGN | Align Technology, Inc. |
| INSP | Inspire Medical Systems, Inc. |
| SWAV | ShockWave Medical, Inc. |